NEU neuren pharmaceuticals limited

Ann: Neuren completes enrolment in Phase 2 trial in Rett Syndrome, page-6

  1. 2,981 Posts.
    lightbulb Created with Sketch. 643
    15-20 weeks away from a company defining moment.

    An investor in NEU is entitled to a certain degree of confidence given the apparent lack of any safety issues and the occasional positive anecdotal postings.

    As EO mentions above, there appears to be solid accumulation from the low of the mid 6's a few weeks back. I'm hoping/expecting that continues up until the announcement (and was pleased to have the opportunity to add a few shares).
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.85
Change
-0.110(0.85%)
Mkt cap ! $1.598B
Open High Low Value Volume
$12.82 $13.05 $12.53 $6.559M 511.8K

Buyers (Bids)

No. Vol. Price($)
1 1657 $12.83
 

Sellers (Offers)

Price($) Vol. No.
$12.85 6303 1
View Market Depth
Last trade - 16.10pm 17/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.